|
|
||||||||
Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA
Reprint requests to: Fred W. McLafferty, Department of Chemistry and Chemical Biology, Cornell University, Baker Laboratory, Ithaca, NY 14853-1301, USA; e-mail: fredwmcl{at}aol.com; fax: (607) 255-7880.
(RECEIVED May 9, 2003; FINAL REVISION July 10, 2003; ACCEPTED July 11, 2003)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.03244403.
| Abstract |
|---|
|
|
|---|
Keywords: Protein oxidation; top-down mass spectrometry; prolyl 4-hydroxylase; 5-oxaproline
| Introduction |
|---|
|
|
|---|
P4H catalyzes the hydroxylation of proline residues in pro-collagens and other proteins that contain collagen-like sequences (Scheme 1
; Prockop and Kivirikko 1995). This reaction requires Fe2+, molecular O2,
-ketoglutarate, and ascorbate as cosubstrates (Prockop and Kivirikko 1995; Kivirikko and Pihlajaniemi 1998), and plays a critical role in the biosynthesis of collagen because 4-hydroxyprolyl residues stabilize the collagen triple-helix. The viral P4H, whose self-oxidation is characterized here, was recently cloned from Paramecium Bursaria Chlorella Virus (PBCV). This enzyme shows sequence similarity to the C-terminal half of the catalytic
-subunit of mammalian P4H (Eriksson et al. 1999).
|
| Results |
|---|
|
|
|---|
|
We have previously demonstrated that oxaproline-containing peptides inactivate human P4H by forming a stable peptide enzyme adduct (Günzler et al. 1988; Wu et al. 1999). We were unable to identify the labeled residue for this interesting inactivation reaction due to intractable solubility problems with the
-subunit of the human enzyme. The high quality spectra that we were able to obtain here prompted us to repeat this experiment with the viral enzyme. We synthesized Pro-Ala-OxaPro-Lys and Pro-Ala-Pro-Lys-OxaPro-Ala-Pro-Lys-Pro-Ala-Pro-Lys, and tested both peptides as mechanism-based inactivating agents. Although both peptides stimulated the hydroxylation of the viral enzyme (Fig. 1e,f
), MS analysis demonstrated that neither peptide covalently labeled the protein.
The time dependence of the oxidation of P4H in the presence of (Pro-Ala-Pro-Lys)2 provides further evidence (Fig. 2
) for the nature of the oxidations. Assuming that the protein hydroxylation requires catalytically competent enzyme, the time course data, as well as the data in Figure 1
, suggest that monohydroxylated and dihydroxylated enzyme are both able to catalyze a further protein hydroxylation. In addition, the observation that all three hydroxylation reactions are occurring at comparable rates suggests that a combination of active site-directed oxidation and oxidation mediated by a reactive oxygen species that has diffused out of the active site is unlikely because such oxidations should show very different rates. The observation that protein oxidation occurs in buffer containing 2 mM ascorbate and 0.1 mM DTT, and that the enzyme is only partially protected by addition of high concentrations of catalase and superoxide dismutase (12P data, Fig. 2
) suggest that the oxidation events are occurring at the active site. Localization of the hydroxylation sites further clarifies this.
|
|
|
|
The +16 Dalton peaks of the b124 and y120 (complement of the b107) ions represent 0.50 and 0.38 proportions, respectively, of the (F + 16)n+ species. The sum of these, 0.88, should represent the oxidation of the whole molecule minus any oxidation in their overlap region (residues 108124), plus some additional for double oxidation that is within the noise level. In good agreement, the Figure 1d
, abundances predict an average of 0.41 + 2 x 0.19 + 3 x 0.05 = 0.94 oxygen atoms per molecular ion. Thus, there is negligible oxidation from residues 108124, plus substantial oxidation between residues 95 to 107 (0.500.22 = 0.28). For residues 125 to 150, the difference (0.380.34 = ~0.04) is close to the value of the experimental error.
Oxidation increase by top-down
To obtain more definitive information on the last oxidation region, the more highly oxygenated (M + 32)2226+ ions were isolated. From IRMPD of these doubly oxidized ions (Fig. 5
), again, only non- and mono-oxidized (+16 Daltons) isoforms are observed within 77 residues from the C terminus, and all are consistent with K216 oxidation. However, the doubly oxidized form (+32 Daltons) has increased from ~3% in y77 to 14% in y105 (Fig. 5
) and y120 (while K216 increased from 34% to 47%), confirming another oxidation location in V125D150 (Fig. 4
). In contrast to the first three oxidations (Fig. 2
), the oxidation rate in the V125D150 region is greatly increased by oxidation at other sites.
|
| Discussion |
|---|
|
|
|---|
-ketoglutarate (Myllyharju and Kivirikko 1997). This suggests that the oxidation of K216 is occurring at the active site. H137 and D139 are also conserved and the corresponding residues in the human P4H are proposed, based on mutagenesis, to function as ligands to the iron (Myllyharju and Kivirikko 1997). This suggests that the oxidized residue on the V125D150 peptide may also be located at the active site. In the absence of a structure, it is not possible to localize further the oxidations at E95F107 or R28V31, although these also contain conserved residues (Fig. 4
Although the K216 oxidation identified here required only a single spectrum (Fig. 3
), this identification would have been complicated with a "bottom-up" approach. The trypsin digest would have produced dozens of peptides in a mass region an order of magnitude smaller than that of the IRMPD/ECD spectra here, complicating the identification and quantitation of the oxidized peptides and, especially, of MS/MS to identify the K216 site. Further, the V125D150 region had only 0.04 oxygens per molecule of the 0.94 total in the Figure 1d
precursors, a nearly impossible noise level for identification of a complement +16-Dalton peptide. By selecting only the dioxygenated molecular ions in the top-down approach, this oxygenated site was easily identified (Fig. 5
, y105 versus y77). Finally, this allowed measurement of kinetic data at two levels of oxidation in the same sample.
| Materials and methods |
|---|
|
|
|---|
-[1-14C] Ketoglutarate was purchased from ARC. Recombinant viral P4H was overexpressed from plasmid pET30b-PBCV-1E36 and purified on a His-Bind Ni2+-chelate affinity column (Novagen; Eriksson et al. 1999). P4H activity was determined using the hydroxylation-coupled decarboxylation of
-[1-14C] ketoglutarate (Kivirikko and Myllylae 1982). 5-Oxaproline (OxaPro) containing peptides were synthesized as described previously (Vasella et al. 1983; Wu et al. 1999) and unmodified peptides were prepared using standard peptide synthesis chemistry.
P4H (250 µg) was incubated at 37°C for 1, 3, and 12 h in a 2-mL total reaction mixture containing 50 mM Tris, pH 7.5, 0.1 mM DTT, 2 mM ascorbate, 0.05 mM FeSO4, 0.5 mM
-ketoglutarate, and 1 mM peptide substrates, Pro-Ala-Pro-Lys, (Pro-Ala-Pro-Lys)2, (Pro-Ala-Pro-Lys)3, Pro-Ala-OxaPro-Lys, and Pro-Ala-Pro-Lys-OxaPro-Ala-Pro-Lys-Pro-Ala-Pro-Lys. The protein was concentrated and desalted into 76:20:4 CH3OH/H2O/CH3COOH using a Centricon 10,000 MWCO centrifugal concentrator (Millipore). This solution was introduced via a nanospray ESI emitter into a modified 6-T Finnigan Fourier-transform (FT) ion cyclotron resonance mass spectrometer (Beu et al. 1993). The outer trapping plates, conventionally used for electron containment (Zubarev et al. 2000), were used for ion trapping. Pulsed nitrogen (~10-6 Torr) was used to assist trapping. For MS/MS spectra, infrared multiphoton dissociation (IRMPD; Little et al. 1994) and "in-beam" activated ion electron capture dissociation (ECD; Horn et al. 2000a) were applied to the protein mixture directly. In some cases, specific ions were isolated using stored waveform inverse FT (Marshall et al. 1985) followed by IRMPD or collisionally activated dissociation (CAD; Gauthier et al. 1991; Senko et al. 1994). The MS/MS spectra were an average of 20100 scans. Assignment of the fragment masses and compositions were made with the computer program THRASH (Horn et al. 2000b). The mass difference (in units of 1.00235 Daltons) between the most abundant isotopic peak and the monoisotopic peak is denoted in italics after each Mr value.
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Andersen, J.S., Svensson, B., and Roepstorff, P. 1996. Electrospray ionization and matrix assisted laser desorption/ionization mass spectrometry: Powerful analytical tools in recombinant protein chemistry. Nat. Biotechnol. 14: 449457.[CrossRef][Medline]
Barlow, J.N., Zhang, Z., John, P., Baldwin, J.E., and Schofield, C.J. 1997. Inactivation of 1-aminocyclopropane-1-carboxylate oxidase involves oxidative modifications. Biochemistry 36: 35633569.[CrossRef][Medline]
Berlett, B.S. and Stadtman, E.R. 1997. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272: 2031320316.
Beu, S.C., Senko, M.W., Quinn, J.P., Wampler III, F.M., and McLafferty, F.W. 1993. Fourier-transform electrospray instrumentation for tandem high-resolution mass spectrometry of large molecules. J. Am. Soc. Mass. Spectrom. 4: 557565.[CrossRef]
Dean, R.T., Fu, S., Stocker, R., and Davies, M.J. 1997. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324: 118.
Dove, J.E. and Klinman, J.P. 2001. Trihydroxyphenylalanine quinone (TPQ) from copper amine oxidases and lysyl tyrosylquinone (LTQ) from lysyl oxidase. Adv. Protein Chem. 58: 141174.[Medline]
Eriksson, M., Myllyharju, J., Tu, H., Hellman, M., and Kivirikko, K.I. 1999. Evidence for 4-hydroxyproline in viral proteins. Characterization of a viral prolyl 4-hydroxylase and its peptide substrates. J. Biol. Chem. 274: 2213122134.
Fridriksson, E.K., Beavil, A., Holowka, D., Gould, H.J., Baird, B., and McLafferty, F.W. 2000. Heterogeneous glycosylation of immunoglobulin E constructs characterized by top-down high-resolution 2-d mass spectrometry. Biochemistry 39: 33693376.[CrossRef][Medline]
Gauthier, J.W., Trautman, T.R., and Jacobson, D.B. 1991. Sustained off-resonance irradiation for collision-activated dissociation involving Fourier transform mass spectrometry. Collision-activated dissociation technique that emulates infrared multiphoton dissociation. Anal. Chim. Acta 246: 211225.[CrossRef]
Ge, Y., Lawhorn, B.G., ElNaggar, M., Strauss, E., Park, J.-H., Begley, T.P., and McLafferty, F.W. 2002. Top down characterization of larger proteins (45 kDa) by electron capture dissociation mass spectrometry. J. Am. Chem. Soc. 124: 672678.[CrossRef][Medline]
Günzler, V., Brocks, D., Henke, S., Myllyla, R., Geiger, R., and Kivirikko, K.I. 1988. Syncatalytic inactivation of prolyl 4-hydroxylase by synthetic peptides containing the unphysiologic amino acid 5-oxaproline. J. Biol. Chem. 263: 1949819504.
Horn, D.M., Ge, Y., and McLafferty, F.W. 2000a. Activated ion electron capture dissociation for mass spectral sequencing of larger (42 kDa) proteins. Anal. Chem. 72: 47784784.[Medline]
Horn, D.M., Zubarev, R.A., and McLafferty, F.W. 2000b. Automated reduction and interpretation of high resolution electrospray mass spectra of large molecules. J. Am. Soc. Mass. Spectrom. 11: 320332.[CrossRef][Medline]
Kelleher, N.L. 2000. From primary structure to function: Biological insights from large-molecule mass spectra. Chem. Biol. 7: R37R45.[CrossRef][Medline]
Kelleher, N.L., Taylor, S.V., Grannis, D., Kinsland, C., Chiu, H.-J., Begley, T.P., and McLafferty, F.W. 1998. Efficient sequence analysis of the six gene products (774 kDa) from the Escherichia coli thiamin biosynthetic operon by tandem high-resolution mass spectrometry. Protein Sci. 7: 17961801.[Abstract]
Kelleher, N.L., Lin, H.Y., Valaskovic, G.A., Aaserud, D.J., Fridriksson, E.K., and McLafferty, F.W. 1999a. Top down versus bottom up protein characterization by tandem high-resolution mass spectrometry. J. Am. Chem. Soc. 121: 806812.[CrossRef]
Kelleher, N.L., Zubarev, R.A., Bush, K., Furie, B., Furie, B.C., McLafferty, F.W., and Walsh, C.T. 1999b. Localization of labile posttranslational modifications by electron capture dissociation: The case of g-carboxyglutamic acid. Anal. Chem. 71: 42504253.[Medline]
Kivirikko, K.I. and Myllylae, R. 1982. Posttranslational enzymes in the biosynthesis of collagen: Intracellular enzymes. Methods Enzymol. 82: 245304.
Kivirikko, K.I. and Pihlajaniemi, T. 1998. Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases. Adv. Enzymol. Related Areas Mol. Biol. 72: 325398.[Medline]
Little, D.P., Speir, J.P., Senko, M.W., OConnor, P.B., and McLafferty, F.W. 1994. Infrared multiphoton dissociation of large multiply charged ions for biomolecule sequencing. Anal. Chem. 66: 28092815.[Medline]
Liu, A., Ho, R.Y.N., Que Jr., L., Ryle, M.J., Phinney, B.S., and Hausinger, R.P. 2001. Alternative reactivity of an a-ketoglutarate-dependent iron(II) oxygenase: Enzyme self-hydroxylation. J. Am. Chem. Soc. 123: 51265127.[CrossRef][Medline]
Mann, M. and Wilm, M. 1994. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem. 66: 43904399.[Medline]
Marshall, A.G., Wang, T.C.L., and Ricca, T.L. 1985. Tailored excitation for Fourier transform ion cyclotron mass spectrometry. J. Am. Chem. Soc. 107: 78937897.[CrossRef]
Meng, F., Cargile, B.J., Miller, L.M., Forbes, A.J., Johnson, J.R., and Kelleher, N.L. 2001. Informatics and multiplexing of intact protein identification in bacteria and the archaea. Nat. Biotechnol. 19: 952957.[CrossRef][Medline]
Myllyharju, J. and Kivirikko, K.I. 1997. Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase. EMBO J. 16: 11731180.[CrossRef][Medline]
Prockop, D.J. and Kivirikko, K.I. 1995. Collagens: Molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64: 403434.[CrossRef][Medline]
Que Jr., L. and Ho, R.Y.N. 1996. Dioxygen activation by enzymes with mononuclear non-heme iron active sites. Chem. Rev. 96: 26072624.[CrossRef][Medline]
Schey, K.L. and Finley, E.L. 2000. Identification of peptide oxidation by tandem mass spectrometry. Acc. Chem. Res. 33: 299306.[CrossRef][Medline]
Senko, M.W., Speir, J.P., and McLafferty, F.W. 1994. Collisional activation of large multiply charged ions using fourier transform mass spectrometry. Anal. Chem. 66: 28012808.[Medline]
Shacter, E. 2000. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32: 307326.[CrossRef][Medline]
Smith, R.D. 2000. Evolution of ESI-mass spectrometry and Fourier transform ion cyclotron resonance for proteomics and other biological applications. Int. J. Mass. Spectrom. 200: 509544.[CrossRef]
Solomon, E.I., Brunold, T.C., Davis, M.I., Kemsley, J.N., Lee, S.K., Lehnert, N., Neese, F., Skulan, A.J., Yang, Y.S., and Zhou, J. 2000. Geometric and electronic structure/function correlations in non-heme iron enzymes. Chem. Rev. 100: 235349.[CrossRef][Medline]
Stadtman, E.R. 1992. Protein oxidation and aging. Science 257: 12201224.
Sze, S.K., Ge, Y., Oh, H., and McLafferty, F.W. 2002. Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue. Proc. Natl. Acad. Sci. 99: 17741779.
. 2003. Plasma electron capture dissociation for the characterization of large proteins by top down mass spectrometry. Anal. Chem. 75: 15991603.[Medline]
Vasella, A., Voeffray, R., Pless, J., and Huguenin, R. 1983. Synthesis of D- and L-5-oxaproline and a new captopril analog. Helv. Chim. Acta 66: 12411252.[CrossRef]
Wilkins, M.R., Gasteiger, E., Gooley, A.A., Herbert, B.R., Molloy, M.P., Binz, P.-A., Ou, K., Sanchez, J.-C., Bairoch, A., Williams, K.L., et al. 1999. High-throughput mass spectrometric discovery of protein post-translational modifications. J. Mol. Biol. 289: 645657.[CrossRef][Medline]
Wu, M., Moon, H.-S., Begley, T.P., Myllyharju, J., and Kivirikko, K.I. 1999. Mechanism-based inactivation of the human prolyl-4-hydroxylase by 5-oxaproline-containing peptides: Evidence for a prolyl radical intermediate. J. Am. Chem. Soc. 121: 587588.[CrossRef]
Yates III, J.R. 2000. Mass spectrometry. From genomics to proteomics. Trends Genet. 16: 58.[Medline]
Zubarev, R.A., Horn, D.M., Fridriksson, E.K., Kelleher, N.L., Kruger, N.A., Lewis, M.A., Carpenter, B.K., and McLafferty, F.W. 2000. Electron capture dissociation for structural characterization of multiply charged protein cations. Anal. Chem. 72: 563573.[Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Zabrouskov, Y. Ge, J. Schwartz, and J. W. Walker Unraveling Molecular Complexity of Phosphorylated Human Cardiac Troponin I by Top Down Electron Capture Dissociation/Electron Transfer Dissociation Mass Spectrometry Mol. Cell. Proteomics, October 1, 2008; 7(10): 1838 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. P. Syka, J. J. Coon, M. J. Schroeder, J. Shabanowitz, and D. F. Hunt Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry PNAS, June 29, 2004; 101(26): 9528 - 9533. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |